322 related articles for article (PubMed ID: 30347865)
1. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and Perspectives.
Wang H; Yang Q; Dou QP; Yang H
Curr Protein Pept Sci; 2018 Feb; 19(4):358-367. PubMed ID: 28079010
[TBL] [Abstract][Full Text] [Related]
3. Cell-based screening of extracts of natural sources to search for inhibitors of the ubiquitin-proteasome system and identification of proteasome inhibitors from the fungus Remotididymella sp.
Nishimura S; Hitora Y; Kawahara T; Tanabe M; Ogata E; Kato H; Srikoon P; Watanabe T; Tsukamoto S
Bioorg Med Chem Lett; 2022 Mar; 59():128566. PubMed ID: 35063633
[TBL] [Abstract][Full Text] [Related]
4. Applied techniques for mining natural proteasome inhibitors.
Stein ML; Groll M
Biochim Biophys Acta; 2014 Jan; 1843(1):26-38. PubMed ID: 23360979
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-Proteasome Modulating Dolabellanes and Secosteroids from Soft Coral
Chiu CY; Ling XH; Wang SK; Duh CY
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31947850
[TBL] [Abstract][Full Text] [Related]
6. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
Tsukamoto S
Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
[TBL] [Abstract][Full Text] [Related]
7. Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1.
Fan Y; You G
Mol Pharmacol; 2020 Jun; 97(6):384-391. PubMed ID: 32234809
[TBL] [Abstract][Full Text] [Related]
8. [The proteasome - structural aspects and inhibitors: a second life for a validated drug target].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):1-23. PubMed ID: 34397372
[TBL] [Abstract][Full Text] [Related]
9. Clogging the Ubiquitin-Proteasome Machinery with Marine Natural Products: Last Decade Update.
Della Sala G; Agriesti F; Mazzoccoli C; Tataranni T; Costantino V; Piccoli C
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30486251
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines.
Hu S; Jin Y; Liu Y; Ljungman M; Neamati N
Eur J Med Chem; 2018 Oct; 158():884-895. PubMed ID: 30253345
[TBL] [Abstract][Full Text] [Related]
11. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.
Mittenberg AG; Kuzyk VO; Shabelnikov SV; Gorbach DP; Shatrova AN; Fedorova OA; Barlev NA
Cell Cycle; 2018; 17(14):1745-1756. PubMed ID: 30009671
[TBL] [Abstract][Full Text] [Related]
13. A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.
Liu N; Liu C; Li X; Liao S; Song W; Yang C; Zhao C; Huang H; Guan L; Zhang P; Liu S; Hua X; Chen X; Zhou P; Lan X; Yi S; Wang S; Wang X; Dou QP; Liu J
Sci Rep; 2014 Jun; 4():5240. PubMed ID: 24912524
[TBL] [Abstract][Full Text] [Related]
14. Structure-Driven Developments of 26S Proteasome Inhibitors.
Śledź P; Baumeister W
Annu Rev Pharmacol Toxicol; 2016; 56():191-209. PubMed ID: 26738474
[TBL] [Abstract][Full Text] [Related]
15. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
Ao N; Chen Q; Liu G
Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteasome inhibitors using analysis of gene expression profiles.
Mofers A; Selvaraju K; Gubat J; D'Arcy P; Linder S
Eur J Pharmacol; 2020 Dec; 889():173709. PubMed ID: 33166494
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.
Xu Y; Yang X; Chen Y; Chen H; Sun H; Li W; Xie Q; Yu L; Shao L
Bioorg Med Chem Lett; 2018 Jul; 28(12):2148-2152. PubMed ID: 29773504
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of microbial proteasome inhibitors.
Momose I; Kawada M
Int Immunopharmacol; 2016 Aug; 37():23-30. PubMed ID: 26589840
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus UL76 elicits novel aggresome formation via interaction with S5a of the ubiquitin proteasome system.
Lin SR; Jiang MJ; Wang HH; Hu CH; Hsu MS; Hsi E; Duh CY; Wang SK
J Virol; 2013 Nov; 87(21):11562-78. PubMed ID: 23966401
[TBL] [Abstract][Full Text] [Related]
20. Novel proteasome inhibitors to overcome bortezomib resistance.
Ruschak AM; Slassi M; Kay LE; Schimmer AD
J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
